Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
4
×
cancer
4
×
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech ipos
cancer immunotherapy
eli lilly
fda
merck
startups
vertex pharmaceuticals
abbvie
What
bio
4
×
roundup
drug
growing
advantages
alliance
alzheimer’s
annual
approved
assessed
attention
bar
biotech
brings
bristol
buy
calls
changing
color
communities
companies
conference
crispr
days
digital
disease
epidemic
esmo
europe
expect
fatty
fda
frenzied
gamble
germany
hosted
hours
investment
known
kudos
Language
unset
Current search:
investing
×
bio
×
cancer
×
" bristol-myers squibb "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More